
The basis of allotment for the ₹250.80 crore Gujarat Kidney and Super Speciality IPO will be announced today, 26 December 2025. Investors can check the IPO allotment status through the official websites of the NSE, BSE, or the IPO’s registrar, MUFG Intime India.
The Gujarat Kidney and Super Speciality IPO is a book-building issue of ₹250.80 crore, consisting entirely of a fresh issue of 2.20 crore shares.
The bidding window was open from December 22, 2025, to December 24, 2025, during which the IPO received a total subscription of 5.21x. The price band is set between ₹108 and ₹114 per share.
The book-running lead manager for the IPO is Nirbhay Capital Services Private Limited, while MUFG Intime India Private Limited (Link Intime) is the registrar for the IPO.
[24 December, 2025, End of the day]
|
Investor Category |
Subscription (Times) |
|
Qualified Institutional Buyers (QIBs) |
1.06 |
|
Non-Institutional Investors |
5.73 |
|
Retail Individual Investors (RIIs) |
19.04 |
|
Total |
5.21 |
According to media reports, the Grey Market Premium (GMP) of the Gujarat Kidney and Super Speciality IPO is reported at nil over the IPO price.
The net proceeds from the fresh issue will be used towards the following objectives:
Gujarat Kidney and Super Speciality Hospital is a super speciality healthcare facility located in Vadodara, Gujarat. The hospital provides a comprehensive range of medical and surgical services, with core expertise in nephrology, urology, renal transplantation, and other high-end specialities. In addition, it offers treatment across general medicine and surgery, cardiology, neurology, oncology, gastroenterology, orthopaedics, and other allied disciplines.
Disclaimer: This news is solely for educational purposes. The securities/investments quoted here are not recommendatory.
To read the RA disclaimer, please click here